Cargando…
Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature
BACKGROUND: The coronavirus disease 2019 (COVID-19) caused by novel coronavirus 2019 in December 2019 has spread all around the globe and has caused a pandemic. There is still no current effective guidance on the clinical management of COVID-19. Mesenchymal stem cell therapy has been shown to be one...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942055/ https://www.ncbi.nlm.nih.gov/pubmed/33728315 http://dx.doi.org/10.12998/wjcc.v9.i7.1705 |